Ecologists are studying resilient reefs to unlock their secrets and preserve others for generations to come

Genetic changes to food crops can't solve all the problems associated with climate change, but they can help

Cheap feedstock from the US tempts chemical makers, but several hurdles stand in the way

A large number of diseases have been linked to the NLRP3 inflammasome. The race is on to develop drugs that disrupt it

Detailed models highlight a key role for solvents

Cement, ethanol, and ammonia makers are among those looking to convert waste carbon to cash

Only 13 % of oxide crystal structures obey 4 of the 5 rules simultaneously

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak

Biogen will pay the biotech firm $350 million upfront and get rights to its therapies for up to 12 neurological diseases

Congress opts for open-ended support for federal and local agencies

Only 13% of oxide crystal structures obey 4 of the 5 rules simultaneously

As the founder of multiple biotech firms, C&EN's guest editor has learned a thing or two about the challenges and triumphs of starting a company. We asked her to share her best advice for budding academic entrepreneurs

Shocked to learn how little plastic gets recycled, the duo founded a company so they could make a difference

Her company, Orchestra Scientific, is developing membrane technology to separate carbon dioxide from other gases and use it as a product

Lucy Therapeutics founder is taking an atypical approach to finding drugs for central nervous system diseases

Her company, MicroByre, is proving that wild microbes can be engineered to produce useful chemicals

Barred as a woman from becoming a brewer in India, Mazumdar-Shaw instead founded biotech firm Biocon and today focuses on affordable health care

Her company, Esya Labs, is developing DNA nanodevices that track drug responses, screen for new therapies, and more

Nanotech pioneer aims to pursue grand challenges rather than just write about them

Prolific biotech business founder says she's always on the lookout for problem-solving opportunities

Nobel Prize winner wants to solve real-world problems with directed evolution

The gene-editing tool CRISPR-Cas9 rerouted Doudna's career path. What hasn't changed for the renowned scientist and serial entrepreneur? Living and breathing the science

With guest editor Jennifer Doudna, CRISPR pioneer

Our collection of chemistry photos will help train an algorithm to recognize lab materials, vessels, and processes

Titanium-dioxide stars lance the skin with microscopic holes to allow medicine through

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun

Congress opts for open-ended support for federal and local agencies

Models predict an ‘alloy' of H and O is a metallic fluid in the ice giants' interior

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun

They persist in the pharma business, even as chemical companies in the West have mostly exited

Companies are making their machines and expertise available to hospitals in need of parts

Chemistry CROs are back in business as rest of world starts to lock down

Italian workers threaten to strike, but German, UK companies and workers pull together

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for COVID-19

Technology could lessen the environmental impact of 3-D printed buildings by adapting locally harvested soils

Lingering logistic problems and a sputtering economy mean hard times for companies

These biomolecules could hold clues to why the virus is so infectious and to how to stop it